 ALAMEDA, Calif.--BUSINESS WIRE--AgeX Therapeutics, Inc. AgeX; NYSE American: AGE, a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2021. Liquidity and Capital Resources As of August 13, 2021, AgeX has 2.0 million of funds remaining for borrowings under two credit facilities from Juvenescence Limited Juvenescence. In addition, AgeX may sell up to 12.1 million of its common sto 